chronic lymphocytic leukemia
Showing NaN - NaN of 61
Chronic Lymphocytic Leukemia Trial in Worldwide (FCR + Lumiliximab, FCR)
Terminated
- Chronic Lymphocytic Leukemia
- FCR + Lumiliximab
- FCR
-
Scottsdale, Arizona
- +193 more
Sep 17, 2015
Chronic Lymphocytic Leukemia Trial in United States (Lumiliximab with FCR)
Completed
- Chronic Lymphocytic Leukemia
- Lumiliximab with FCR
-
Birmingham, Alabama
- +4 more
Sep 17, 2015
Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia Trial in Columbus (Alvocidib Hydrochloride, Lenalidomide,
Completed
- Anemia
- +5 more
- Alvocidib Hydrochloride
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 1, 2015
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Chicago, Rochester, Columbus (Motexafin Gadolinium)
Terminated
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Motexafin Gadolinium
-
Chicago, Illinois
- +2 more
May 7, 2014
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Augusta, Columbus, Nashville (XmAb5574)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- XmAb5574
-
Augusta, Georgia
- +2 more
Apr 18, 2014
Chronic Lymphocytic Leukemia Trial in New Hyde Park, Columbus, Nashville (Dasatinib, Combination of Bendamustine + Dasatinib)
Withdrawn
- Chronic Lymphocytic Leukemia
- Dasatinib
- Combination of Bendamustine + Dasatinib
-
New Hyde Park, New York
- +2 more
Jul 19, 2013
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
Completed
- Chronic Lymphocytic Leukemia
-
San Diego, California
- +4 more
Feb 25, 2011
Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)
Unknown status
- Chronic Lymphocytic Leukemia
- +5 more
- Lenalidomide and Rituximab
-
La Jolla, California
- +4 more
Sep 8, 2010